Literature DB >> 10030387

Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma.

F Matsuura1, S Yamashita, K Hirano, M Ishigami, H Hiraoka, R Tamura, T Nakagawa, M Nishida, N Sakai, T Nakamura, S Nozaki, T Funahashi, C Matsumoto, M Higashiyama, K Yoshikawa, Y Matsuzawa.   

Abstract

Necrobiotic xanthogranuloma (NXG) is a rare histiocytic disease with generalized xanthomatosis. However, most cases with NXG are normolipidemic or hypolipidemic. The mechanism for the formation of xanthoma in NXG has not yet been clarified. We observed a case of NXG with severe hypocholesterolemia (total cholesterol: 1.69 mmol/l) and analyzed the function of monocytes in this case. Histological examinations by light microscopy revealed a large amount of lipid deposition in the patient's freshly isolated monocytes. The patient's monocytes showed a 3-fold increase in cholesteryl ester content and a 3-fold enhancement of acetyl low density lipoprotein (LDL) uptake compared with the control monocytes. However, no significant difference was noted in the expression of CD36 protein and the mRNA levels of scavenger receptor-class A (SR-A) between the monocytes of the patient and the control. The phagocytotic ability of the patient's monocytes was enhanced 1.5-fold compared with that of the control monocytes. These findings suggest that the activated monocytes may have degraded the modified LDL via a pathway other than CD36 or SR-A, and accumulated a great amount of lipids in vivo. In conclusion, the present study has demonstrated a possible pathogenesis of NXG that the activation of monocytes in vivo may contribute to the intracellular accumulation of lipoprotein-derived lipids leading to non-inherited xanthomatosis and the marked hypocholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030387     DOI: 10.1016/s0021-9150(98)00260-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  Expression of stabilin-1 in M2 macrophages in human granulomatous disease and melanocytic lesions.

Authors:  Kathrin Schönhaar; Kai Schledzewski; Julia Michel; Claudia Dollt; Cleopatra Gkaniatsou; Cyrill Géraud; Julia Kzhyshkowska; Sergij Goerdt; Astrid Schmieder
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

3.  Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis.

Authors:  M Jeziorska; A Hassan; M I Mackness; D E Woolley; A B Tullo; G S Lucas; P N Durrington
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

4.  Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.

Authors:  Huaizhu Wu; R Michael Gower; Hong Wang; Xiao-Yuan Dai Perrard; Ruidong Ma; Daniel C Bullard; Alan R Burns; Antoni Paul; C Wayne Smith; Scott I Simon; Christie M Ballantyne
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690

5.  Necrobiotic xanthogranuloma and chronic lymphocytic leukemia of the conjunctiva masquerading as scleritis and uveitis.

Authors:  Amir Mohsenin; John Sinard; John J Huang
Journal:  Clin Ophthalmol       Date:  2012-12-13

6.  Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.

Authors:  Ioannis Tsakiris; Daniel Torocsik; Adrienn Gyongyosi; Aniko Dozsa; Istvan Szatmari; Attila Szanto; Gyorgyike Soos; Zoltan Nemes; Laszlo Igali; Ildiko Marton; Zoltan Takats; Laszlo Nagy; Balazs Dezso
Journal:  Lab Invest       Date:  2011-12-12       Impact factor: 5.662

7.  Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma.

Authors:  Marlies Wruhs; Robert Feldmann; Isabelle Sawetz; Friedrich Breier; Andreas Steiner
Journal:  Case Rep Dermatol       Date:  2016-12-01

8.  Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma.

Authors:  Joon Goon Kim; Hye Ri Kim; Moon Hyung You; Dong Hoon Shin; Jong Soo Choi; Young Kyung Bae
Journal:  Ann Dermatol       Date:  2019-12-27       Impact factor: 1.444

9.  Spectacular skin nodules: cutaneous necrobiotic xanthogranuloma without paraproteinemia.

Authors:  Shimoni Kadakia; Nitin Nadkarni; Sham Sonavane; Sunil Ghate
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

10.  Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.

Authors:  R Szalat; J Pirault; J-P Fermand; A Carrié; F Saint-Charles; M Olivier; P Robillard; E Frisdal; E F Villard; P Cathébras; E Bruckert; M John Chapman; P Giral; M Guerin; P Lesnik; W Le Goff
Journal:  J Intern Med       Date:  2014-02-10       Impact factor: 8.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.